Findings suggest drugs can now be developed to stall the growth of K-Ras cancers, previously deemed impossible to treat NYU Langone Medical Center researchers have found a biological weakness in the workings of the most commonly mutated ...
Tags: K-Ras, DNA, radiation, Mutated Gene
Patients with a common form of lung cancer — lung squamous cell carcinoma — have very few treatment options. That situation may soon change. A team of cancer biologists at Mayo Clinic in Florida is reporting in the Feb. 10 ...
Tags: Oncogene, lung cancer, PKCiota, SOX2
Researchers at Brigham and Women's Hospital and Carnegie Mellon University Announce a unique micro-robotic technique to assemble the components of complex materials Researchers at Brigham and Women's Hospital (BWH) and Carnegie Mellon ...
Tags: 3D Printing, Tissue Engineering, Micro-Robotic Technique, BWH
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of ...
Tags: Identify New Drug Candidates, unparalleled selectivity, cell permeable
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy. There is currently no proven screening test or method ...
Tags: QUT, ovarian cancer, Katie Clift, 3D modelling
Stem cells can turn into heart cells, skin cells can mutate to cancer cells; even cells of the same tissue type exhibit small heterogeneities. Scientists use single-cell analysis to investigate these heterogeneities. But the method is still ...
Tags: Consumer Electronics, Electronics, Biological Single-Cell
Harvard stem cells scientists at Brigham and Women's Hospital and MIT can now engineer cells that are more easily controlled following transplantation, potentially making cell therapies, hundreds of which are currently in clinical trials ...
Tags: stem cells
The drugs Mekinist and Tafinlar were approved for combination treatment of advanced melanoma skin cancer, the U.S. Food and Drug Administration announced Friday. The two medicines "are the first drugs approved for combination treatment of ...
Tags: FDA, 2-Drug Combo Treatment, Combo Treatment for Advanced Melanoma
The U.S. Food and Drug Administration approved Mekinist, or trametinib, in combination with Tafinlar, or dabrafenib, to treat patients with advanced melanoma. Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products ...
Tags: Skin Cancer, Health, Medicine
Researchers have developed a technique for creating nanoparticles that carry two different cancer-killing drugs into the body and deliver those drugs to separate parts of the cancer cell where they will be most effective. The technique was ...
Tags: create nanoparticles, cancer-killing drugs, breast cancer, cancer cell
Scientists have obtained the first detailed molecular structure of a member of the Tet family of enzymes. The finding is important for the field of epigenetics because Tet enzymes chemically modify DNA, changing signposts that tell the ...
Tags: enzymes, epigenetics, Tet enzymes
Metabolism was lost in the shadows of cancer research for decades but has recently been reclaiming some of the spotlight. Now, Mina Bissell, Distinguished Scientist with Berkeley Lab's Life Sciences Division and a leading authority on ...
According to the National Institutes of Health (NIH), Alzheimer's disease (AD) -- which robs people of the ability to think, remember and reason -- is an irreversible, progressive disease that eventually destroys even the ability to carry ...
You may think that eating five superfoods every day is out of reach, not very do-able. There are quite a few superfoods available, and many articles list up to ten to consume. Some of those superfoods, however, may not be practical ...
"There is not one, but many cures for cancer available. But they are all being systematically suppressed by ... the major oncology centers. They have too much of an interest in the status quo," stated Dr Robert Atkins, MD, creator of the ...